Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Chabner

Showing results (191-200 of 245) with videos related to

Pageof 25
Sort By:
Bulletin Du Cancer|January 1, 1979
Potential clinical applications of a new method for quantitation of plasma levels of 5-fluorouracil and 5-fluorodeoxyuridineR A Jones, A R Buckpitt, H H Londer, et al.
Clinical Pharmacology and Therapeutics|June 1, 1974
Treatment of malignant melanoma with methyl CCNUR C Young, G P Canellos, B A Chabner, et al.
Cancer|May 1, 1973
Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU)R C Young, M D Walker, G P Canellos, et al.
British Medical Journal|February 9, 1974
Cyclical combination chemotherapy for advanced breast carcinomaG P Canellos, V T Devita, G L Gold, et al.
The Oncologist|November 7, 1999
A staff dialogue on a socially distanced patient: psychosocial issues faced by patients, their families, and caregiversA Goodman, R T Penson, R Blatman, et al.
The Oncologist|March 8, 2000
Sedation for intractable distress of a dying patient: acute palliative care and the principle of double effectE L Krakauer, R T Penson, R D Truog, et al.
Blood|June 1, 1976
Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapyG P Canellos, V T DeVita, J Whang-Peng, et al.
Cancer|November 1, 1978
Hexamethylmelamine in alkylating agent-resistant ovarian carcinomaB L Johnson, R I Fisher, R A Bender, et al.
Annals of Internal Medicine|April 1, 1976
Combination chemotherapy for advanced breast cancer: response and effect on survivalG P Canellos, V T DeVita, G L Gold, et al.
Gynecologic Oncology|December 1, 1974
Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamideR C Young, G P Canellos, B A Chabner, et al.
Pageof 25

Showing results (191-200 of 245) with videos related to

Sort By:
Pageof 25
Bulletin Du Cancer|January 1, 1979
Potential clinical applications of a new method for quantitation of plasma levels of 5-fluorouracil and 5-fluorodeoxyuridineR A Jones, A R Buckpitt, H H Londer, et al.
Clinical Pharmacology and Therapeutics|June 1, 1974
Treatment of malignant melanoma with methyl CCNUR C Young, G P Canellos, B A Chabner, et al.
Cancer|May 1, 1973
Initial clinical trials with methyl-CCNU 1-(2-chlorethyl)-3-(4-methyl cyclohexyl)-1-nitrosourea (MeCCNU)R C Young, M D Walker, G P Canellos, et al.
British Medical Journal|February 9, 1974
Cyclical combination chemotherapy for advanced breast carcinomaG P Canellos, V T Devita, G L Gold, et al.
The Oncologist|November 7, 1999
A staff dialogue on a socially distanced patient: psychosocial issues faced by patients, their families, and caregiversA Goodman, R T Penson, R Blatman, et al.
The Oncologist|March 8, 2000
Sedation for intractable distress of a dying patient: acute palliative care and the principle of double effectE L Krakauer, R T Penson, R D Truog, et al.
Blood|June 1, 1976
Chemotherapy of the blastic phase of chronic granulocytic leukemia: hypodiploidy and response to therapyG P Canellos, V T DeVita, J Whang-Peng, et al.
Cancer|November 1, 1978
Hexamethylmelamine in alkylating agent-resistant ovarian carcinomaB L Johnson, R I Fisher, R A Bender, et al.
Annals of Internal Medicine|April 1, 1976
Combination chemotherapy for advanced breast cancer: response and effect on survivalG P Canellos, V T DeVita, G L Gold, et al.
Gynecologic Oncology|December 1, 1974
Chemotherapy of advanced ovarian carcinoma: a prospective randomized comparison of phenylalanine mustard and high dose cyclophosphamideR C Young, G P Canellos, B A Chabner, et al.
Pageof 25